The full list of differentially expressed proteins was compared to the list of aging biomarkers in blood determined by the TAME working group (Justice et al. 2018), see full list of APs in Table S2d. Of the seven aging biomarkers selected by TAME as gold standard, five proteins (CST3, GDF15, IL6, NPPB, TNF) were available and significantly differentially expressed when comparing healthy controls with centenarians or with geriatric patients; two proteins (CRP, IGF1) were unavailable from the Olink panels (Cardiometabolic I and Inflammation I).
On the expanded list of blood-based biomarkers (74 total) selected by TAME, when comparing healthy controls with centenarians, 47 biomarkers were not available in both panels (63.5%). Of the available markers, 23 were significantly differentially expressed in centenarians (85.2%) and 4 were not significantly differentially expressed in centenarians (14.8%). When comparing healthy controls with geriatric patients, 47 biomarkers were not available in both panels (63.5%); 25 were significantly differentially expressed in the geriatric group (92.6%), and only 2 were not significantly differentially expressed in hospitalized geriatric patients (7.4%). Only 2 proteins (SERPINE1, SOD1) among the 25 proteins available in the SWISS100 dataset demonstrated different results in both comparisons (Healthy2Cent and Healthy2Geriatric). Thus, both the short and expanded list of blood-based biomarkers proposed by TAME as APs are highly reproducible in the SWISS100 study based on proximity extension assay. Table S2d contains the complete list of DEPs in blood with age that overlap between both studies.